| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Departments of Biochemistry [R. M. S., A. S. B.], Pathology [S. S.], and Anatomy [B. P.], Loyola University of Chicago, Stritch School of Medicine, Maywood, Illinois 60153; and Synergen, Inc., Boulder, Colorado 80301 [D. F. C.]
The human tissue inhibitor of metalloproteinases (TIMP) is a glycoprotein with a molecular weight of 28,000. It appears to be ubiquitous in human mesoderm tissues and has previously been shown to be identical to the collagenase inhibitor isolated from human skin fibroblasts. TIMP inhibits type I- and IV-specific collagenases and other neutral metalloen-doproteinases that may be responsible for the degradation of extracellular matrix in tumor cell metastasis. In this work we have utilized recombinant human TIMP (rTIMP) obtained by expression of its cDNA gene (Carmichael et al., Proc. Natl. Acad. Sci. USA, 83: 2407, 1986). The rTIMP is shown to have similar inhibition properties as natural TIMP against human skin fibroblast collagenase. In an in vitro amnion invasion assay system, rTIMP inhibited the invasion of B16-F10 murine melanoma cells through the human amniotic membrane at an identical concentration to that reported previously for natural TIMP. The mechanism by which rTIMP inhibits amniotic membrane invasion was compared to the mechanism by which the fibronectin receptor binding peptide RGDS and the laminin receptor binding peptide YIGSR inhibit amnion invasion. RGDS and YIGSR inhibited strong binding of the tumor cells to the amniotic membrane. In contrast rTIMP did not inhibit the cell adhesion step in amnion invasion, but actually increased the number of tumor cells that were tightly bound to the amnion. Thus rTIMP appears to inhibit a later step in the amnion invasion process, following B16-F10 cell adhesion. C57BL/6 mice treated with i.p. injections of rTIMP every 12 h for 6.5 days showed a significant inhibition of metastatic lung colonization by B16-F10 murine melanoma cells. While the rTIMP inhibited the number of metastatic lung tumors formed, it had no significant effect on the size of the lung tumors. Furthermore, tumors grown s.c. in mice receiving 12-h i.p. injections of rTIMP for 6.5 days, as in the in vivo colonization assay, showed no difference in size from controls. Thus the anticolonization effect of rTIMP appears not to be due to an effect on tumor growth, but on the invasion step itself. The inhibition of lung colonization in C57BL/6 mice by rTIMP is one of the first examples showing an antimetastatic effect of a selective metalloproteinase inhibitor in a mammalian animal model, and supports an essential role for metalloproteinase(s) in the extravasation and invasion of tumor cells during lung colonization by blood-borne tumor cells.
1 Supported in part by NIH Grants CA43305 (R. M. S.) and CA44659 (A. S. B.), Potts Foundation Grant 842-35 (B. P.), and by Synergen, Inc. (R. M. S.).
2 To whom requests for reprints should be addressed, at Department of Biochemistry and Biophysics Loyola University, Stritch School of Medicine, 2160 South First Avenue, Maywood, IL 60153.
Received 11/13/87. Revised 5/25/88. Accepted 7/ 5/88.
This article has been cited by other articles:
|
|
 |
|
  I. V. Sorensen, C. Fenger, H. Winther, N. T. Foged, U. Lademann, N. Brunner, and P. A. Usher Characterization of Anti-TIMP-1 Monoclonal Antibodies for Immunohistochemical Localization in Formalin-fixed, Paraffin-embedded Tissue J. Histochem. Cytochem., October 1, 2006; 54(10): 1075 - 1086. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. J. Lubbe, Z. Y. Zhou, W. Fu, D. Zuzga, S. Schulz, R. Fridman, R. J. Muschel, S. A. Waldman, and G. M. Pitari Tumor epithelial cell matrix metalloproteinase 9 is a target for antimetastatic therapy in colorectal cancer. Clin. Cancer Res., March 15, 2006; 12(6): 1876 - 1882. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H.-J. Kwak, M.-J. Park, H. Cho, C.-M. Park, S.-I. Moon, H.-C. Lee, I.-C. Park, M.-S. Kim, C. H. Rhee, and S.-I. Hong Transforming Growth Factor-{beta}1 Induces Tissue Inhibitor of Metalloproteinase-1 Expression via Activation of Extracellular Signal-Regulated Kinase and Sp1 in Human Fibrosarcoma Cells Mol. Cancer Res., March 1, 2006; 4(3): 209 - 220. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Yamazaki, T. Akahane, T. Buck, H. Yoshiji, D. E. Gomez, D. J. Schoeffner, E. Okajima, S. R. Harris, O. R. Bunce, S. S. Thorgeirsson, et al. Long-term exposure to elevated levels of circulating TIMP-1 but not mammary TIMP-1 suppresses growth of mammary carcinomas in transgenic mice Carcinogenesis, September 1, 2004; 25(9): 1735 - 1746. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-S. Rhee, R. Diaz, L. Korets, J. G. Hodgson, and L. M. Coussens TIMP-1 Alters Susceptibility to Carcinogenesis Cancer Res., February 1, 2004; 64(3): 952 - 961. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-W. Tien, P.-H. Lee, R.-H. Hu, S.-M. Hsu, and K.-J. Chang The Role of Gelatinase in Hepatic Metastasis of Colorectal Cancer Clin. Cancer Res., October 15, 2003; 9(13): 4891 - 4896. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. M. Coussens, B. Fingleton, and L. M. Matrisian Matrix Metalloproteinase Inhibitors and Cancer--Trials and Tribulations Science, March 29, 2002; 295(5564): 2387 - 2392. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Cianfrocca, T. P. Cooley, J. Y. Lee, M. A. Rudek, D. T. Scadden, L. Ratner, J. M. Pluda, W. D. Figg, S. E. Krown, and B. J. Dezube Matrix Metalloproteinase Inhibitor COL-3 in the Treatment of AIDS-Related Kaposi's Sarcoma: A Phase I AIDS Malignancy Consortium Study J. Clin. Oncol., January 1, 2002; 20(1): 153 - 159. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. C. Durkan, J. E. Nutt, P. H. Rajjayabun, D. E. Neal, J. Lunec, and J. K. Mellon Prognostic Significance of Matrix Metalloproteinase-1 and Tissue Inhibitor of Metalloproteinase-1 in Voided Urine Samples from Patients with Transitional Cell Carcinoma of the Bladder Clin. Cancer Res., November 1, 2001; 7(11): 3450 - 3456. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Hoekstra, F.A.L.M. Eskens, and J. Verweij Matrix Metalloproteinase Inhibitors: Current Developments and Future Perspectives Oncologist, October 1, 2001; 6(5): 415 - 427. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Faveeuw, G. Preece, and A. Ager Transendothelial migration of lymphocytes across high endothelial venules into lymph nodes is affected by metalloproteinases Blood, August 1, 2001; 98(3): 688 - 695. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Jiang, M. Wang, M. Y. Çeliker, Y. E. Liu, Q. X. Amy Sang, I. D. Goldberg, and Y. E. Shi Stimulation of Mammary Tumorigenesis by Systemic Tissue Inhibitor of Matrix Metalloproteinase 4 Gene Delivery Cancer Res., March 1, 2001; 61(6): 2365 - 2370. [Abstract] [Full Text]
|
|
|
|
 |
|
 L. M. Grønning, J. E. Wang, A. H. Ree, T. B. Haugen, K. Taskén, and K. A. Taskén Regulation of Tissue Inhibitor of Metalloproteinases-1 in Rat Sertoli Cells: Induction by Germ Cell Residual Bodies, Interleukin-1{alpha}, and Second Messengers Biol Reprod, April 1, 2000; 62(4): 1040 - 1046. [Abstract] [Full Text]
|
|
|
|
|
|
A. R. Nelson, B. Fingleton, M. L. Rothenberg, and L. M. Matrisian Matrix Metalloproteinases: Biologic Activity and Clinical Implications J. Clin. Oncol., March 1, 2000; 18(5): 1135 - 1135. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Koochekpour, M. Jeffers, P. H. Wang, C. Gong, G. A. Taylor, L. M. Roessler, R. Stearman, J. R. Vasselli, W. G. Stetler-Stevenson, W. G. Kaelin Jr., et al. The von Hippel-Lindau Tumor Suppressor Gene Inhibits Hepatocyte Growth Factor/Scatter Factor-Induced Invasion and Branching Morphogenesis in Renal Carcinoma Cells Mol. Cell. Biol., September 1, 1999; 19(9): 5902 - 5912. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. BLAVIER, P. HENRIET, S. IMREN, and Y. A. DECLERCK Tissue Inhibitors of Matrix Metalloproteinases in Cancer Ann. N.Y. Acad. Sci., June 30, 1999; 878(1): 108 - 119. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Ries, F. Loher, C. Zang, M. G. Ismair, and P. E. Petrides Matrix Metalloproteinase Production by Bone Marrow Mononuclear Cells from Normal Individuals and Patients with Acute and Chronic Myeloid Leukemia or Myelodysplastic Syndromes Clin. Cancer Res., May 1, 1999; 5(5): 1115 - 1124. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G Cox, W P Steward, and K J O'Byrne The plasmin cascade and matrix metalloproteinases in non-small cell lung cancer Thorax, February 1, 1999; 54(2): 169 - 179. [Full Text]
|
|
|
|
|
|
A. Kruger, J. E. Fata, and R. Khokha Altered Tumor Growth and Metastasis of a T-Cell Lymphoma in Timp-1 Transgenic Mice Blood, September 1, 1997; 90(5): 1993 - 2000. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. F. Singer, A. Rasmussen, M. E. Lippman, and K. J. Cullen Coexpression of Stromelysin-3 and Insulin-Like Growth Factor II in Tumors of Ectodermal, Mesodermal, and Endodermal Origin: Indicator of a Fetal Cell Phenotype J. Clin. Endocrinol. Metab., June 1, 1997; 82(6): 1917 - 1922. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Moses The Regulation of Neovascularization by Matrix Metalloproteinases and Their Inhibitors Stem Cells, May 1, 1997; 15(3): 180 - 189. [Abstract] [Full Text]
|
|
|
|
 |
|
 N. Zempo, N. Koyama, R. D. Kenagy, H. J. Lea, and A. W. Clowes Regulation of Vascular Smooth Muscle Cell Migration and Proliferation In Vitro and in Injured Rat Arteries by a Synthetic Matrix Metalloproteinase Inhibitor Arterioscler. Thromb. Vasc. Biol., January 1, 1996; 16(1): 28 - 33. [Abstract] [Full Text]
|
|
|
|
|
|
R Khokha, P Waterhouse, S Yagel, P. Lala, C. Overall, G Norton, and D. Denhardt Antisense RNA-induced reduction in murine TIMP levels confers oncogenicity on Swiss 3T3 cells Science, February 17, 1989; 243(4893): 947 - 950. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
